Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | F7 | P08709 | 2/20 | 0.47 |
| ▸ | F3 | P13726 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | TERT | O14746 | 3/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | PPARD | Q03181 | 3/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL808761 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3PRKCAFAAH | |
| SCHEMBL15237135 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3PRKCAFAAH | |
| SCHEMBL1898702 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL31019571 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL31084293 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL1301154 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL434985 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL6479269 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL592739 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT | |
| SCHEMBL1301724 | 0.96 | F7 (0.53) | F7F3PRKCAFAAHTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731002-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2026-04-29 | — | — | EP | claimed |
| WO-2024263793-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2024-12-26 | — | — | WO | claimed |
| EP-1395534-B1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | MATERIA INC (US) | 2017-08-30 | — | — | EP | claimed |
| US-6900347-B2 | Impurity inhibition in olefin metathesis reactions | TILLIECHEM, INC. (US) | 2005-05-31 | — | — | US | claimed |
| EP-1395534-A1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | Pederson, Richard L. (US) | 2004-03-10 | — | — | EP | claimed |
| US-20030023123-A1 | Impurity inhibition in olefin metathesis reactions | MATERIA, INC. | 2003-01-30 | — | — | US | claimed |
| WO-2002094748-A1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | PEDERSON RICHARD L (US) | 2002-11-28 | — | — | WO | claimed |
| EP-4731002-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2024263793-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| EP-3416729-B1 | PRO-FRAGRANCE COMPOSITION | AQDOT LTD (GB) | 2023-09-20 | — | — | EP | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| US-6900347-B2 | Impurity inhibition in olefin metathesis reactions | TILLIECHEM, INC. (US) | 2005-05-31 | — | — | US | disclosed |
| US-6838576-B1 | Process for preparing functional group-containing olefinic compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-01-04 | — | — | US | disclosed |
| EP-1395534-A1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | Pederson, Richard L. (US) | 2004-03-10 | — | — | EP | disclosed |
| US-20030023123-A1 | Impurity inhibition in olefin metathesis reactions | MATERIA, INC. | 2003-01-30 | — | — | US | disclosed |
| WO-2002094748-A1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | PEDERSON RICHARD L (US) | 2002-11-28 | — | — | WO | disclosed |
| US-3984478-A | TREATING AN UNSATURATED COMPOUND WITH CARBON MONOXIDE IN A HETEROGENEOUS CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3949007-A | METAL HYDROXIDE OR ALKOXIDE CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | ALDH1A1 978/4885F7 3076/4885F3 3955/4885 |
| US-20030023123-A1 | Impurity inhibition in olefin metathesis reactions | CYP51A1, CYP1B1, SQLE | ALDH1A1 513/4885F7 2395/4885F3 500/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | ALDH1A1 978/4885F7 3076/4885F3 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.